Ashmore Group Valuation
Is ASHM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of ASHM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: ASHM (£1.95) wird unter unserer Schätzung des Fair Value (£1.97) gehandelt.
Deutlich unter dem Marktwert: ASHM unter dem beizulegenden Zeitwert gehandelt wird, jedoch nicht um einen signifikanten Betrag.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ASHM?
Other financial metrics that can be useful for relative valuation.
| What is ASHM's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | UK£1.30b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.3x |
| Enterprise Value/EBITDA | 7.4x |
| PEG Ratio | -4.8x |
Price to Earnings Ratio vs Peers
How does ASHM's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 18.9x | ||
QLT Quilter | 34.2x | 28.3% | UK£1.4b |
CLDN Caledonia Investments | 14.2x | n/a | UK£1.8b |
OCI Oakley Capital Investments | 17.5x | n/a | UK£830.9m |
N91 Ninety One Group | 9.8x | -2.5% | UK£1.6b |
ASHM Ashmore Group | 13.2x | -2.7% | UK£1.3b |
Price-To-Earnings gegen Gleichaltrige: ASHM ist ein guter Wert, wenn man sein Price-To-Earnings Verhältnis (14.7x) mit dem Durchschnitt der anderen Unternehmen (47.4x) vergleicht.
Price to Earnings Ratio vs Industry
How does ASHM's PE Ratio compare vs other companies in the GB Capital Markets Industry?
Price-To-Earnings gegen Industrie: ASHM ist aufgrund seines Price-To-Earnings Verhältnisses (13.9x) im Vergleich zum UK Capital Markets Branchendurchschnitt (14.1x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is ASHM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 13.2x |
| Fair PE Ratio | 12.1x |
PM vs. Fair Ratio: ASHM ist teuer auf der Grundlage des Verhältnisses Price-To-Earnings (14.7x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (12.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | UK£1.96 | UK£2.05 +4.4% | 16.8% | UK£2.85 | UK£1.50 | n/a | 12 |
| Mar ’25 | UK£2.05 | UK£2.05 +0.2% | 16.6% | UK£2.85 | UK£1.50 | n/a | 12 |
| Feb ’25 | UK£2.09 | UK£2.03 -2.9% | 17.2% | UK£2.85 | UK£1.50 | n/a | 12 |
| Jan ’25 | UK£2.23 | UK£1.90 -14.7% | 20.6% | UK£2.85 | UK£1.50 | n/a | 12 |
| Dec ’24 | UK£1.79 | UK£1.90 +6.0% | 20.7% | UK£2.85 | UK£1.50 | n/a | 12 |
| Nov ’24 | UK£1.70 | UK£1.96 +15.3% | 20.5% | UK£2.85 | UK£1.50 | n/a | 12 |
| Oct ’24 | UK£1.88 | UK£2.08 +10.8% | 17.3% | UK£2.85 | UK£1.60 | n/a | 12 |
| Sep ’24 | UK£1.94 | UK£2.22 +14.5% | 15.0% | UK£2.85 | UK£1.75 | n/a | 11 |
| Aug ’24 | UK£2.03 | UK£2.24 +9.9% | 14.8% | UK£2.85 | UK£1.75 | n/a | 11 |
| Jul ’24 | UK£2.08 | UK£2.40 +15.5% | 14.4% | UK£2.85 | UK£1.90 | n/a | 11 |
| Jun ’24 | UK£2.28 | UK£2.40 +5.4% | 14.4% | UK£2.85 | UK£1.90 | n/a | 11 |
| May ’24 | UK£2.43 | UK£2.40 -1.2% | 14.4% | UK£2.85 | UK£1.90 | n/a | 11 |
| Apr ’24 | UK£2.39 | UK£2.46 +3.2% | 13.0% | UK£2.95 | UK£2.00 | UK£1.96 | 11 |
| Mar ’24 | UK£2.68 | UK£2.46 -8.1% | 13.0% | UK£2.95 | UK£2.00 | UK£2.05 | 11 |
| Feb ’24 | UK£2.69 | UK£2.41 -10.2% | 17.3% | UK£2.85 | UK£1.65 | UK£2.09 | 11 |
| Jan ’24 | UK£2.39 | UK£2.25 -6.1% | 16.1% | UK£2.85 | UK£1.65 | UK£2.23 | 11 |
| Dec ’23 | UK£2.30 | UK£2.22 -3.2% | 17.4% | UK£2.85 | UK£1.65 | UK£1.79 | 11 |
| Nov ’23 | UK£2.16 | UK£2.18 +1.2% | 17.3% | UK£2.85 | UK£1.65 | UK£1.70 | 12 |
| Oct ’23 | UK£1.97 | UK£2.38 +20.8% | 14.3% | UK£2.90 | UK£1.85 | UK£1.88 | 12 |
| Sep ’23 | UK£1.94 | UK£2.28 +17.4% | 16.9% | UK£2.90 | UK£1.70 | UK£1.94 | 14 |
| Aug ’23 | UK£2.17 | UK£2.28 +4.9% | 17.1% | UK£2.90 | UK£1.70 | UK£2.03 | 14 |
| Jul ’23 | UK£2.19 | UK£2.82 +28.9% | 24.0% | UK£4.20 | UK£2.00 | UK£2.08 | 14 |
| Jun ’23 | UK£2.42 | UK£2.83 +17.0% | 24.2% | UK£4.20 | UK£2.00 | UK£2.28 | 13 |
| May ’23 | UK£2.23 | UK£2.87 +28.9% | 22.5% | UK£4.20 | UK£2.00 | UK£2.43 | 14 |
| Apr ’23 | UK£2.34 | UK£3.02 +29.1% | 21.3% | UK£4.20 | UK£2.00 | UK£2.39 | 14 |
Analysten-Prognose: Das Kursziel liegt weniger als 20% über dem aktuellen Aktienkurs.